778 - ImmuPharma #IMM Falanx #FLX and Eric Burns on #DFX

May 17, 2017, 11:15 AM

On Today’s Vox Markets Podcast:

Tim McCarthy, Chairman of ImmuPharma #IMM gives and update, on its lead compound, Lupuzor™ in its pivotal Phase III study. (Interview starts at 1 minute 19 seconds)

Falanx Group #FLX CEO, Stuart Bladen and Director Jay Abbot discuss the recent ransomware cyber attack on the NHS. (Interview starts at 11 minutes 51 seconds)

Eric Burns, Deputy Head of Institutional Research at WH Ireland also talks about the recent cyber attack and discusses some companies that will help you gain exposure to the growing cyber protection market, including: Defenx Group #DFX (Interview starts at 21 minutes 23 seconds)

Plus the Top 5 Most Followed Companies on Vox Markets in the last 24 hours & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours. (Feature starts at 31 minutes 10 seconds)

Vox Markets is a stock market resource platform, that aggregates investor relations information.

It specialises in the latest stock market news, company information, live prices, interviews and views from Asset Managers, Stock Brokers, Hedge Fund Managers, Private Investors, Independent Financial Advisors and Investment Managers.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast

https://www.voxmarkets.co.uk/